Research and Development

Showing 15 posts of 9603 posts found.

GSK signs RNA therapeutics alliance

March 31, 2010 Research and Development GlaxoSmithKline, Isis, RNA

GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …

Boehringer enters the venture capital business

March 31, 2010 Research and Development, Sales and Marketing Boehringer, funding, venture capital

Boehringer Ingelheim is to tap into commercial opportunities in emerging technology by launching its own venture capital business. The Boehringer …

Lilly expands trial supply deal with Thermo

March 31, 2010 Manufacturing and Production, Research and Development Thermo Fisher Scientifitic, lilly

Eli Lilly has expanded a clinical trial materials supply agreement with Thermo Fisher Scientific in yet another deal that sees …

Contract research news in brief

March 30, 2010 Research and Development CRO, Kendle

This week’s round-up of news in the contract research arena includes a fundraising for Irish CRO Venn Life Sciences, ISO …

Antisoma cancer drug fails in phase III

March 29, 2010 Research and Development Antisoma, NSCLC, lung cancer

UK biotech Antisoma has suffered a disappointing late-stage failure with a potential lung cancer treatment it was developing with Novartis. …

Funding boost for UK research

March 29, 2010 Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome

Prime minister Gordon Brown has pledged £250 million for the planned UK Centre for Medical Research and Innovation (UKCMRI). The …
CLR teamsheet1

Manches promotes Catherine Rohll

March 25, 2010 Business Services, Research and Development Manches, appointment, business services

UK law firm Manches has promoted Catherine Rohll to partner in its life sciences team.A scientist by training with a …

Vernalis diabetes pain drug fails in phase II

March 24, 2010 Research and Development Vernalis

Vernalis’ new treatment for neuropathic pain has disappointed in phase II trials and will now be dropped for this indication. …

Adverse event halts Merck cancer vaccine trial

March 23, 2010 Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines

Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …

PPD boosts position in flu vaccine research

March 23, 2010 Research and Development CRO, PPD, Southern Research Institute, vaccines

PPD is collaborating with the Southern Research Institute in the US to tap into the growing market for contract research …

CHMP in brief: Hospira’s Nivestim approved

March 22, 2010 Research and Development EMA

A round-up of decisions from the Committee for Medicinal Products for Human Use (CHMP), including its recommendation for a chewable version …

Pfizer’s Kindler elected PhRMA chairman

March 22, 2010 Research and Development, Sales and Marketing PhRMA, appointment, research and development, sales and marketing

Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …

Merck joins coalition for biosecurity vaccine plant

March 22, 2010 Manufacturing and Production, Research and Development biodefence, vaccines

Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …

Baxter Alzheimer’s candidate shows promise

March 20, 2010 Research and Development Alzheimer's, baxter

Baxter’s Gammagard has shown promise in treating Alzheimer’s disease, with patients showing better cognitive function and less brain enlargement than …
The Gateway to Local Adoption Series

Latest content